PET/CT诊断子宫内膜癌的优势及展望

doi:10.11904/j.issn.1002-3070.2018.02.011

摘要/Abstract

摘要： 子宫内膜癌是妇科三大恶性肿瘤之一。与传统的影像学检查方法相比,PET/CT集合了解剖及分子显像的特点,本文分别阐述了其在转移性淋巴结的检出、监测疾病复发及评价预后的优势,并与MRI技术比较,阐述了两者之间的互补作用,随着PET的新型示踪剂及PET/MRI技术的发展,PET/CT的应用前景更为广阔。

关键词: 子宫内膜癌, 复发, 转移, 预后

Abstract: Endometrial cancer is one of three major gynecological malignancies.When compared with the traditional imaging methods,PET/CT combines the characteristics of anatomy and molecular imaging.In this paper,we describe its advantages in detection of metastatic lymph nodes,monitoring of disease recurrence and prognosis.The complementary effect is compared between PET and CT with MRI.With the development of new tracer and PET/MRI technology,the application of PET/CT is more extensive.

Key words: Endometrial cancer, Recurrence, Metastasis, Prognosis

中图分类号:

R445.5

龚伟, Md Tofiz Uddin, 陆佩欧, 于丽娟. PET/CT诊断子宫内膜癌的优势及展望[J]. 实用肿瘤学杂志, 2018, 32(2): 144-148.

GONG Wei, Md Tofiz Uddin, LU Peiou, YU Lijuan. Advantages and prospects of PET/CT in the diagnosis of endometrial cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 144-148.

参考文献

1 Kim HJ,Cho A,Yun M,et al.Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer[J].Ann Nucl Med,2016,30(2):104-113.
2 Kakhki VR,Shahriari S,Treglia G,et al.Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients:systematic review and meta-analysis of the literature[J].Int J Gynecol Cancer,2013,23(9):1536-1543.
3 张莉.MRI对子宫内膜癌浸润、淋巴结转移、宫颈间质受累的诊断价值分析[J].中国CT和MRI杂志,2016,14(3):88-90.
4 Antonsen SL,Jensen LN,Loft A,et al.MRI,PET/CT and ultrasound in the preoperative staging of endometrial cancer-a multicenter prospective comparative study[J].Gynecol Oncol,2013,128(2):300-308.
5 Koplay M,Dogan NU,Erdogan H,et al.Diagnostic efficacy of diffusion-weighted MRI for pre-operative assessment of myometrial and cervical invasion and pelvic lymph node metastasis in endometrial carcinoma[J].J Med Imaging Radiat Oncol,2014,58(5):538-546.
6 Simcock B,Narayan K,Drummond E,et al.The role of positron emission tomography/computed tomography in planning radiotherapy in endometrial cancer[J].Int J Gynecol Cancer,2015,25(4):645-649.
7 Amit A,Person O,Keidar Z.FDG PET/CT in monitoring response to treatment in gynecological malignancies[J].Curr Opin Obstet Gynecol,2013,25(1):17-22.
8 宁秋萍,蔡莉,陈秋松,等.女性正常子宫内膜及卵巢对¹⁸F-FDG的生理性摄取特点[J].中国医学影像技术,2011(6):1247-1250.
9 王颖,黄浩,仲勇,等.子宫内膜癌诊治进展及争议焦点[J].医学理论与实践,2016,29(6):732-734.
10 Denschlag D,Ulrich U,Emons G.The diagnosis and treatment of endometrial cancer:progress and controversies[J].Dtsch Arztebl Int,2010,108(34/35):571-577.
11 Antonsen SL,Loft A,Fisker R,et al.SUV_max of ¹⁸FDG PET/CT as a predictor of high-risk endometrial cancer patients[J].Gynecol Oncol,2013,129(2):298-303.
12 Nogami Y,Banno K,Irie H,et al.The efficacy of preoperative positron emission tomography-computed tomography(PET-CT)for detection of lymph node metastasis in cervical and endometrial cancer:clinical and pathological factors influencing it[J].Jpn J Clin Oncol,2015,45(1):26-34.
13 Chang MC,Chen JH,Liang JA,et al.¹⁸F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer:a systematic review and meta-analysis.[J].Eur J Radiol,2012,81(11):3511-3517.
14 Crivellaro C,Signorelli M,Guerra L,et al.Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer:the role of ¹⁸F-FDG PET/CT[J].Gynecol Oncol,2013,130(2):306-311.
15 Kitajima K,Suenaga Y,Ueno Y,et al.Preoperative risk stratification using metabolic parameters of ¹⁸F-FDG PET/CT in patients with endometrial cancer[J].Eur J Nucl Med Mol Imaging,2015,42(8):1268-1275.
16 Fung-Kee-Fung M,Dodge J,Elit L,et al.Follow-up after primary therapy for endometrial cancer:a systematic review[J].Gynecol Oncol,2006,101(3):520-529.
17 Sorbe B,Juresta C,Ahlin C.Natural history of recurrences in endometrial carcinoma[J].Oncol Lett,2014,8(4):1800-1806.
18 Shim SH,Kim DY,Lee DY,et al.Metabolic tumour volume and total lesion glycolysis,measured using preoperative ¹⁸F-FDG PET/CT,predict the recurrence of endometrial cancer[J].BJOG,2014,121(9):1097-1106.
19 Kadkhodayan S,Shahriari S,Treglia G,et al.Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients:systematic review and meta-analysis of the literature[J].Gynecol Oncol,2013,128(2):397-404.
20 Sharma P,Kumar R,Singh H,et al.Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma:comparison with conventional imaging[J].Nucl Med Commun,2012,33(2):185-190.
21 Fotopoulou C,El-Balat A,du Bois A,et al.Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer[J].Arch Gynecol Obstet,2015,292(6):1321-1327.
22 Walentowicz-Sadlecka M,Malkowski B,Walentowicz P,et al.The preoperative maximum standardized uptake value measured by ¹⁸F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients[J].Biomed Res Int,2014,2014:234813.
23 张凤仙,张建,陈素芸,等.¹⁸F-FDG PET/CT显像SUV_max对子宫内膜癌术前浸润及转移的评估价值[J].中华核医学与分子影像杂志,2017,37(2):75-80.
24 Husby JA,Reitan BC,Biermann M,et al.Metabolic tumor volume on ¹⁸F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients[J].J Nucl Med,2015,56(8):1191-1198.
25 Haldorsen IS,Salvesen HB.What is the best preoperative imaging for endometrial cancer?[J].Curr Oncol Rep,2016,18(4):25.
26 Lee HJ,Ahn BC,Hong CM,et al.Preoperative risk stratification using(18)F-FDG PET/CT in women with endometrial cancer[J].Nuklearmedizin,2011,50(5):204-213.
27 Challapalli A.New radiotracers in gynecological cancer:beyond ¹⁸F-FDG[J].Q J Nucl Med Mol Imaging,2016,60(2):139-153.
28 Vercellino LS,Groheux D,Delord M,et al.Hypoxia imaging of uterine cervix carcinoma with ¹⁸F-FETNIM PET[J].Eur J Nucl Med Mol Imaging,2011,38(11):120.
29 Grigsby PW,Malyapa RS,Higashikubo R,et al.Comparison of molecular markers of hypoxia and imaging with 60Cu-ATSM in cancer of the uterine cervix[J].Mol Imaging Biol,2007,9(5):278-283.
30 Tsujikawa T,Yoshida Y,Kiyono Y,et al.Functional oestrogen receptor alpha imaging in endometrial carcinoma using 16alpha-¹⁸F fluoro-17beta-oestradiol PET[J].Eur J Nucl Med Mol Imaging,2011,38(1):37-45.
31 Beiderwellen K,Grueneisen J,Ruhlmann V,et al.[¹⁸F]FDG PET/MRI vs.PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis:initial results[J].Eur J Nucl Med Mol Imaging,2015,42(1):56-65.
32 Shih IL,Yen RF,Chen CA,et al.Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR:correlation with pathological prognostic factors[J].J Magn Reson Imaging,2015,42(6):1723-1732.

[1]	王晓雅,肖斌,廖扬,唐荣芝,孙朝晖,李林海. CXCR家族蛋白在不同乳腺癌亚型中的表达及临床预后分析[J]. 实用肿瘤学杂志, 2019, 33(3): 206-210.
[2]	孟海,杜观祥,朱利玲,汤琪云. WEE1在胃癌组织中的表达及对患者预后的影响[J]. 实用肿瘤学杂志, 2019, 33(3): 239-243.
[3]	李嘉琪,栾瑾微,张,玉,李香兰. 763例三阴性乳腺癌临床病理特征及复发、转移影响因素分析[J]. 实用肿瘤学杂志, 2019, 33(3): 244-249.
[4]	冯越,邢丽楠,王棹,张云艳. NLR与肿瘤同步放化疗预后的相关性研究[J]. 实用肿瘤学杂志, 2019, 33(3): 284-288.
[5]	白晓斌, 霍龙伟, 谢万福, 徐高峰, 王茂德. Chk1在胶质母细胞瘤中的表达及其与肿瘤生物学行为和预后生存的关联性[J]. 实用肿瘤学杂志, 2019, 33(2): 122-127.
[6]	石小康, 丁佑铭, 汪斌, 余斌, 徐雨. UBE2T在原发性肝癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2019, 33(2): 128-133.
[7]	方琳, 刘超, 张纯慧, 张艳桥. 转移性结直肠癌维持治疗的研究现状与治疗策略[J]. 实用肿瘤学杂志, 2019, 33(2): 173-178.
[8]	卢姣云, 张清媛. 实验室标志物在弥漫大B细胞淋巴瘤预后中的研究进展[J]. 实用肿瘤学杂志, 2019, 33(2): 183-187.
[9]	赵凤娟, 王琪, 任贇虹, 韦珏伶, 黎乐群, 赵新华, 唐娟, 游雪梅. 肝癌伴抑郁患者血清CRP、hs-CRP水平变化及其对预后的影响[J]. 实用肿瘤学杂志, 2019, 33(1): 27-33.
[10]	张凤春, 江莺, 刘照南, 闫宁宁, 崔洪全, 徐迎春. 系统性炎症相关指标中性粒细胞/淋巴细胞比值及血小板/淋巴细胞比值在根治性切除术后的胃癌患者的预后意义[J]. 实用肿瘤学杂志, 2019, 33(1): 34-39.
[11]	马健力, 张明辉, 姬宏飞, 徐向英. PD-L1蛋白与CD8⁺TILs联合检测在可切除肺腺癌预后评估中的临床意义[J]. 实用肿瘤学杂志, 2019, 33(1): 40-46.
[12]	杨洪波, 石洁, 叶勇, 李文成, 邓兆平. COL5A2在膀胱癌组织中的表达及其与临床病理特征和预后的相关性分析[J]. 实用肿瘤学杂志, 2019, 33(1): 52-56.
[13]	张攀, 张迪综述, 戴晓波审校. 复发鼻咽癌再程放射治疗的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 92-96.
[14]	于芳, 赵培. TRAP1在食管癌发展中的作用及机制研究[J]. 实用肿瘤学杂志, 2018, 32(6): 515-519.
[15]	王亚龙, 吕章艳, 张帆, 冯小双, 魏锣沛, 李鑫, 温艳, 高禹舜, 薛奇, 高树庚, 谭锋维. 人乳头状瘤病毒感染与肺癌预后相关性的Meta分析[J]. 实用肿瘤学杂志, 2018, 32(6): 520-526.